Galaxy Medical announced today that it received CE mark approval in Europe for its Centauri pulsed electric field (PEF) system.
San Carlos, California-based Galaxy Medical designed its Centauri system to target arrhythmias by delivering quick bursts of high-voltage, high-frequency energy for the treatment of paroxysmal AFib.
The company said in a news release that Centauri is the first commercially available system to enable PEF ablation with focal catheters which are used in the majority of cardiac ablation procedures worldwide.
“From the beginning, we designed Centauri to be the workhorse PEF system for all electrophysiology labs, enabling physicians to maintain use of their favored mapping systems and catheters,” Galaxy Medical CEO Dr. Jonathan Waldstreicher said in the release. “Our goal is to provide a safer and more effective alternative to thermal ablation for all practitioners of cardiac arrhythmia ablation, and the CE mark allo…